Tactical Medicine News Blog

SARCOPENIA by IntraMed

Posted by EMS Solutions International on

 Dr Ramon REYES, MD, [24/02/2023 15:48]Introducción    La sarcopenia describe la pérdida acelerada del músculo esquelético, manifestándose como una combinación de baja fuerza y baja masa muscular.     La fragilidad puede describirse como un deterioro colectivo en múltiples sistemas corporales, lo que conduce a una menor capacidad de mantener la homeostasis y responder a las tensiones fisiológicas...

Read more →


ACMT Toxicology Visual Pearl: Is the Silver Bullet for Refractory Vasoplegia Really Blue?

Posted by Parker Hambright, MD on

What is the proposed mechanism for the pictured antidote when used as a pressor for refractory vasoplegic shock? Alpha-1-adrenergic agonist Angiotensin II receptor antagonist Nitric oxide/cyclic GMP pathway inhibition Vasopressin-1 receptor agonist

Read more →


Electrostatic Face Mask Self-Charges with Breathing

Posted by Conn Hastings on

Researchers at City University of Hong Kong have developed an electrostatically charged face mask that can replenish its charge through the wearer’s breathing action. The electrostatic charge helps the mask to adsorb tiny particles, such as SARS-CoV-2 viruses. However, such masks typically lose their charge and ability to bind particles over time, particularly in humid […]

Read more →


NextGen COVID-19 Antibodies Destroy Spike Protein

Posted by Conn Hastings on

Researchers at the Garvan Institute of Medical Research in Australia have developed a new generation of antibodies to treat COVID-19. So far, the antibodies have been shown to neutralize several of the viral variants behind COVID-19, and the researchers hope that they will form an effective treatment for at-risk patients. Previously developed antibody treatments for […]

Read more →


Europa vigila el (Paracetamol +Pseudoefedrina) Gelocatil, el Frenadol y otros medicamentos para la gripe tras casos de daños cerebrales

Posted by EMS Solutions International on

 Prospecto pdf La Agencia Europea de Medicamentos (EMA) ha iniciado una revisión de los medicamentos que contienen pseudoefedrina, usada para tratar la congestión nasal causada por un resfriado, gripe o alergia, debido a las preocupaciones que existen por el riesgo de desarrollar enfermedades que afectan a los vasos sanguíneos del cerebro.El comité de seguridad (PRAC) de la EMA está revisando...

Read more →


Go to full site